Details : These studies show that ILB® releases, re-distributes and modulates the bioactivity of endogeneous heparin-binding growth factors that target disease compromised nervous tissues to initiate a cascade of transcriptional, metabolic and immunological effec...
Brand Name : ILB
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 31, 2022
Details : The collaboration will support TikoMed's lead drug platform candidate ILB®, a broad-spectrum small molecule drug candidate with curative potential and clinical development, regulatory and commercial strategies.
Brand Name : ILB
Molecule Type : Small molecule
Upfront Cash : Undisclosed
May 05, 2022
LOOKING FOR A SUPPLIER?